Summit Global Investments - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 181 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2023$2,315
+1.5%
96,485
-1.8%
0.18%
-7.3%
Q4 2022$2,281
-99.9%
98,301
+0.4%
0.19%
+33.1%
Q3 2022$1,569,000
-19.9%
97,934
-11.5%
0.14%
-16.2%
Q2 2022$1,960,000
+77.2%
110,606
+103.7%
0.17%
+111.0%
Q1 2022$1,106,000
-26.1%
54,300
-32.2%
0.08%
-14.6%
Q4 2021$1,496,000
+9.8%
80,100
+16.1%
0.10%
-5.9%
Q3 2021$1,362,000
+100.9%
69,000
+140.4%
0.10%
+148.8%
Q2 2021$678,00028,7000.04%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q4 2022
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders